Phibro Animal Health Corporation — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$374M↑+20.9%$27M↑+762.1%13.5%
2025-09-30$364M↑+39.7%$27M↑+280.3%14.1%
2025-06-30$379M↑+38.6%$17M↑+2190.4%8.9%
2025-03-31$348M↑+32.1%$21M↑+148.4%9.6%
2024-12-31$309M↑+23.7%$3M↑+150.0%8.3%
2024-09-30$260M↑+12.6%$7M↑+187.0%6.8%
2024-06-30$273M↑+7.1%$752K↓-93.5%6.7%
2024-03-31$263M↑+7.1%$8M↓-16.3%7.6%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$374M
↑+20.9% +$65M YoY
Net Income
$27M
↑+762.1% +$24M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 55 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+2.5pts
35.5%
Operating Margin↑+5.2pts
13.5%
Net Margin↑+6.3pts
7.3%

Go deeper